In vitro amyloid fibril formation by synthetic peptides corresponding to the amino terminus of apoSAA isoforms from amyloid-susceptible and amyloid- resistant mice

Journal of Structural Biology

Volumn 124, Issue 1, 1998, Pages 88-98

  Kirschner, Daniel A ^a   Elliott Bryant, Rosemary ^b   Szumowski, Karen E ^a   Gonnerman, Wayne A ^c   Kindy, Mark S ^d   Sipe, Jean D ^c   Cathcart, Edgar S ^b,c  

^a BOSTON COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Electron microscopy; Fibrillogenesis; Self assembly; X ray diffraction; conformation

Indexed keywords

AMYLOID;

AMINO ACID SEQUENCE; ARTICLE; ELECTRON MICROSCOPY; HYDROGEN BOND; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; STRUCTURE ANALYSIS; X RAY DIFFRACTION;

EID: 0032447487     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1998.4047     Document Type: Article

References (51)

1. Aggeli, A., Bell, M., Boden, N., Keen, J. N., Knowles, P. F., McLeish, T. C. B., Pitkeathly, M., and Radford, S. E. (1997) Responsive gels formed by the spontaneous self-assembly of peptides into polymeric β-sheet tapes, Nature 386, 259-262.
2. Alexander, L. E. (1969) X-Ray Diffraction Methods in Polymer Science, Wiley, New York.
3. Bonar, L., Cohen, A. S., and Skinner, M. M. (1969) Characterization of the amyloid fibril as a cross-β fibril, Proc. Soc. Exp. Biol. Med. 131, 1373-1375.
4. Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dolson, C. M., Radford, S. E., Blake, C. C., and Pepys, M. B. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis, Nature 385, 787-793.
5. Chothia, C., and Murzin, A. G. (1993) New folds for all-beta proteins, Structure 1, 217-222.
6. de Beer, M. C., de Beer, F. C., McCubbin, W. D., Kay, C. M., and Kindy, M. S. (1993) Structural prerequisites for serum amyloid A fibril formation, J. Biol. Chem. 268, 20606-20612.
7. Dwulet, F. E., Wallace, D. K., and Benson, M. D. (1988) Amino acid structures of multiple forms of amyloid-related serum protein SAA from a single individual, Biochemistry 27, 1677-1682.
8. Eanes, E. D., and Glenner, G. G. (1969) X-ray diffraction studies on amyloid filaments, J. Histochem. Cytochem. 16, 673-677.
9. Elliott-Bryant, R., Liang, J.-S., Sipe, J. D., and Cathcart, E. S. (1998) Catabolism in vitro of lipid-free recombinant apolipoprotein serum amyloid A by mouse macrophages results in removal of the amyloid fibril-forming amino terminus, Scand. J. Immunol. 48, 241-247.
10. Fraser, P. E., Duffy, L. K., O'Malley, M. B., Nguyen, J., Inouye, H., and Kirschner, D. A. (1991) Morphology and antibody recognition of synthetic β-amyloid peptides, J. Neurosci. Res. 28, 474-185.
11. Fraser, P. E., Nguyen, J. T., Chin, D. T., and Kirschner, D. A. (1992a) Effects of sulfate ions on Alzheimer β/A4 peptide assemblies: Implications for amyloid fibril-proteoglycan interactions, J. Neurochem. 59, 1531-1540.
12. Fraser, P. E., Nguyen, J. T., Inouye, H., Surewicz, W. K., Selkoe, D. J., Podlisny, M. B., and Kirschner, D. A. (1992b) Fibril formation by primate, rodent, and Dutch-hemorrhagic analogues of Alzheimer amyloid β-protein, Biochemistry 31, 10716-10723.
13. 1-antitrypsin and implications for amyloid toxicity, Neurodegeneration 2, 155-163.
14. Geddes, A. J., Parker, K. D., Atkins, E. D. T., and Beighton, E. (1968) Cross-β conformation in proteins, J. Mol. Biol. 32, 343-358.
15. Gonnerman, W. A., Elliott-Bryant, R., Carreras, I., Sipe, J. D., and Cathcart, E. S. (1995) Linkage of protection against amyloid fibril formation in the mouse to a single, autosomal dominant gene, J. Exp. Med. 181, 2249-2252.
16. Gowing, E., Roher, A. E., Woods, A. S., Cotter, R. J., Chaney, M., Little, S. P., and Ball, M. J. (1994) Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease, J. Biol. Chem. 269, 10987-10990.
17. Hoffman, J. S., Ericsson, L. H., Eriksen, N., Walsh, K. A., and Benditt, E. P. (1984) Murine tissue amyloid protein AA: NH2-terminal sequence identity with only one of two serum amyloid protein (apoSAA) gene products, J. Exp. Med. 159, 641-646.
18. Inouye, H., and Kirschner, D. A. (1996) Refined fibril structures: The hydrophobic core in Alzheimer's β-amyloid and prion as revealed by x-ray diffraction, in The Nature and Origin of Amyloid Fibrils, pp. 22-35. Ciba Foundation Symposium No. 199.
19. Inouye, H., and Kirschner, D. A. (1997) X-ray diffraction analysis of scrapie prion: Intermediate and folded structures in a peptide containing two putative α-helices, J. Mol. Biol. 268, 375-389.
20. Inouye, H., and Kirschner, D. A. (1998) Polypeptide chain folding in the hydrophobic core of hamster scrapie prion: Analysis by x-ray diffraction, J. Struct. Biol. 122, 247-255.
21. Inouye, H., Fraser, P. E., and Kirschner, D. A. (1993) Structure of β-crystallite assemblies formed by Alzheimer β-amyloid protein analogues: Analysis by X-ray diffraction, Biophys. J. 64, 502-519.
22. Inouye, H., Karthigasan, J., and Kirschner, D. A. (1989) Membrane structure in isolated and intact myelins, Biophys. J. 56, 129-137.
23. Kelly, J. W. (1996) Alternative conformations of amyloidogenic proteins govern their behavior, Curr. Opin. Struct. Biol. 6, 11-17.
24. Kisilevsky, R., and Snow, A. (1988) The potential significance of sulphated glycosaminoglycans as a common constituent of all amyloids: Or, perhaps amyloid is not a misnomer, Med. Hypoth. 26, 231-236.
25. Lotz, B., Gonthier-Vassal, A., Brack, A., and Magoshi, J. (1982) Twisted single crystals of Bombyx mori silk fibroin and related model polypeptides with β structure, J. Mol. Biol. 156, 345-357.
26. Lowell, C. A., Potter, D. A., Stearman, R. S., and Morrow, J. F. (1986) Structure of the murine serum amyloid A gene family. Gene conversion, J. Biol. Chem. 261, 8442-8452.
27. Malinchik, S. B., Inouye, H., Szumowski, K. E., and Kirschner, D. A. (1998) Structural analysis of Alzheimer's β(1-40) amyloid: Protofilament assembly of tubular fibrils, Biophys. J. 74, 537-545.
28. May, P. C., Gitter, B. D., Waters, D. C., Simmons, L. K., Becker, G. W., Small, J. S., and Robison, P. M. (1992) β-Amyloid peptide in vitro toxicity: lot-to-lot variability, Neurobiol. Aging 13, 605-607.
29. Meek, R. L., Hoffman, J. S., and Benditt, E. P. (1986) Amyloidogenesis: one serum amyloid A isotype is selectively removed from the circulation, J. Exp. Med. 163, 499-510.
30. Nguyen, J. T., Inouye, H., Baldwin, M. A., Fletterick, R. J., Cohen, F. E., Prusiner, S. B., and Kirschner, D. A. (1995) X-ray diffraction of scrapie prion rods and PrP peptides, J. Mol. Biol. 252, 412-422.
31. Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C., Terry, C. J., Feest, T. G., Zalin, A. M., and Hsuan, J. J. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis, Nature 362, 553-557.
32. Perutz, M. F. (1997) Amyloid fibrils: Mutations make enzyme polymerize, Nature 385, 773.
33. Pike, C. J., Overman, M. J., and Cotman, C. W. (1995) Aminoterminal deletions enhance aggregation of beta-amyloid peptides in vitro, J. Biol. Chem. 270, 23895-23898.
34. Prusiner, S. B., McKinley, M. P., Bowman, K. A., Bolton, D. C., Benheim, P. E., Groth, D. F., and Glenner, G. G. (1983) Scrapie prions aggregate to form amyloid-like birefringent rods, Cell 35, 349-358.
35. Ranlov, P., and Wanstrup, J. (1968) Ultrastructural investigations on the cellular morphogenesis of experimental amyloidosis, Acta Pathol. Microbiol. Scand. 72, 233-236.
36. Raynes, J. G., and McAdam, K. P. (1991) Serum amyloid A isoforms in inflammation, Scand. J. Immunol. 33, 657-666.
37. Shen, C.-L., Fitzgerald, M. C., and Murphy, R. M. (1994) Effect of acid predissolution on fibril size and fibril flexibility of synthetic β-amyloid peptide, Biophys. J. 67, 1238-1246.
38. Shiroo, M., Kawahara, E., Nakanishi, I., and Migita, S. (1987) Specific deposition of serum amyloid A protein 2 in the mouse, Scand. J. Immunol. 26, 709-716.
39. Simmons, L. K., May, P. C., Tomaselli, K. J., Rydel, R. E., Fuson, K. S., Brigham, E. F., Wright, S., Lieberburg, I., Becker, G. W., and Brems, D. N. (1994) Secondary structure of amyloid beta peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol. 45, 373-379.
40. Sipe, J. D. (1992) Amyloidosis, Annu. Rev. Biochem. 61, 947-975.
41. Sipe, J. D., Carreras, I., Gonnerman, W. A., Cathcart, E. S., de Beer, M. C., and de Beer, F. C. (1993) Characterization of the inbred CE/J mouse strain as amyloid resistant, Am. J. Pathol. 143, 1480-1485.
42. Snow, A. D., and Castillo, G. M. (1997) Specific proteoglycans as potential causative agents and relevant targets for therapeutic intervention in Alzheimer's disease and other amyloidoses, Amyloid 4, 135-141.
43. Strachan, A. F., de Beer, F. C., van der Westhuyzen, D. R., and Coetzee, G. A. (1988) Identification of three isoform patterns of human serum amyloid A protein, Biochem. J. 250, 203-207.
44. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., and Blake, C. C. F. (1997) Common core structure of amyloid fibrils by synchrotron x-ray diffraction, J. Mol. Biol. 273, 729-739.
45. Syversen, P. V., Sletten, K., and Husby, G. (1991) Evolutionary aspects of protein SAA, in Natvig, J. B., Forre, O., Husby, G., Husebekk, A., Skogen, B., Sletten, K., Westermark, P. (Eds.), Amyloid and Amyloidosis, pp. 111-114. Kluwer Academic, Dordrecht, The Netherlands.
46. Takahashi, M., Yokota, T., Kawano, H., Gondo, T., Ishihara, T., and Uchino, F. (1989) Ultrastructural evidence for intracellular formation of amyloid fibrils in macrophages, Virchows Arch. A415, 411-419.
47. Tibbitts, T. T., and Caspar, D. L. D. (1993) Deconvolution of disoriented fiber diffraction data using iterative convolution and local regression, Acta Crystallogr. A49, 532-545.
48. Westermark, G. T., Engstrom, U., and Westermark, P. (1992) The N-terminal segment of protein AA determines its fibrillogenic property, Biochem. Biophys. Res. Commun. 182, 27-33.
49. Yamada, T., Kluve-Beckerman, B., Liepniks, J. J., and Benson, M. D. (1994) Fibril formation from recombinant human serum amyloid A, Biochim. Biophys. Acta 1226, 323-329.
50. Yamamoto, K., Shiroo, M., and Migita, S. (1986) Diverse gene expression for isotypes of murine serum amyloid A protein during acute phase reaction, Science 232, 227-229.
51. Yamamoto, K., and Migita, S. (1985) Complete primary structures of two major murine serum amyloid A proteins deduced from cDNA sequences, Proc. Natl. Acad. Sci. USA 82, 2915-2919.